Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600521.SS Stock Summary
In the News
600521.SS Financial details
Company Rating
Strong Buy
Market Cap
19.12B
Income
1.09B
Revenue
8.64B
Book val./share
5.61
Cash/share
0.82
Dividend
0.24
Dividend %
1.76%
Employees
7.68K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
17.93
Forward P/E
13.18
PEG
1.45
P/S
2.28
P/B
2.43
P/C
15.76
P/FCF
-55.37
Quick Ratio
0.86
Current Ratio
1.63
Debt / Equity
0.86
LT Debt / Equity
0.56
-
-
EPS (TTM)
0.76
EPS next Y
0.98
EPS next Q
0.2
EPS this Y
138.24%
EPS next Y
28.29%
EPS next 5Y
28.29%
EPS last 5Y
58.18%
Revenue last 5Y
10.16%
Revenue Q/Q
-14.4%
EPS Q/Q
-59.26%
-
-
-
-
SMA20
-7.14%
SMA50
-7.14%
SMA100
-18.75%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
14%
ROC
0.1%
Gross Margin
61%
Oper. Margin
17%
Profit Margin
13%
Payout
51%
Shs Outstand
1.44B
Shs Float
810.81M
-
-
-
-
Target Price
-
52W Range
10.71-21.03
52W High
-38.48%
52W Low
+29.2%
RSI
37
Rel Volume
0.64
Avg Volume
11.14M
Volume
7.09M
Perf Week
-5.9%
Perf Month
-4.58%
Perf Quarter
-
Perf Half Y
-23.82%
-
-
-
-
Beta
0.126
-
-
Volatility
0.34%, 0.33%
Prev Close
1.1%
Price
12.92
Change
-0.77%
600521.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.88 | 3.88 | 4.46 | 4.63 | 5.73 | |
Net income per share | 0.08 | 0.41 | 0.64 | 0.34 | 0.81 | |
Operating cash flow per share | 0.05 | 1.26 | 1.07 | 0.65 | 0.86 | |
Free cash flow per share | -0.8 | 0.69 | 0.19 | -1.04 | -0.74 | |
Cash per share | 0.69 | 1.07 | 1.52 | 1.31 | 1.05 | |
Book value per share | 3.1 | 4.04 | 4.48 | 4.57 | 5.23 | |
Tangible book value per share | 2.49 | 3.43 | 3.76 | 3.65 | 4.09 | |
Share holders equity per share | 3.1 | 4.04 | 4.48 | 4.57 | 5.23 | |
Interest debt per share | 2.81 | 2.54 | 2.88 | 4.05 | 4.91 | |
Market cap | 12.5B | 21.8B | 49.12B | 31.06B | 31.52B | |
Enterprise value | 15.14B | 23.6B | 50.96B | 34.82B | 37.01B | |
P/E ratio | 116.23 | 38.27 | 52.83 | 63.71 | 26.99 | |
Price to sales ratio | 2.45 | 4.05 | 7.57 | 4.68 | 3.81 | |
POCF ratio | 184.06 | 12.43 | 31.58 | 33.1 | 25.36 | |
PFCF ratio | -11.83 | 22.71 | 176.08 | -20.76 | -29.35 | |
P/B Ratio | 3.07 | 3.89 | 7.54 | 4.74 | 4.18 | |
PTB ratio | 3.07 | 3.89 | 7.54 | 4.74 | 4.18 | |
EV to sales | 2.97 | 4.38 | 7.86 | 5.24 | 4.48 | |
Enterprise value over EBITDA | 19.56 | 15.8 | 26.99 | 22.28 | 14.7 | |
EV to operating cash flow | 222.97 | 13.46 | 32.76 | 37.1 | 29.78 | |
EV to free cash flow | -14.33 | 24.59 | 182.67 | -23.27 | -34.48 | |
Earnings yield | 0.01 | 0.03 | 0.02 | 0.02 | 0.04 | |
Free cash flow yield | -0.08 | 0.04 | 0.01 | -0.05 | -0.03 | |
Debt to equity | 0.87 | 0.59 | 0.62 | 0.86 | 0.91 | |
Debt to assets | 0.34 | 0.31 | 0.31 | 0.36 | 0.38 | |
Net debt to EBITDA | 3.41 | 1.21 | 0.97 | 2.41 | 2.18 | |
Current ratio | 1.09 | 1.57 | 2.26 | 1.61 | 1.65 | |
Interest coverage | 3.4 | 3.67 | 9.51 | 5.22 | 7.03 | |
Income quality | 0.5 | 2.89 | 1.56 | 1.95 | 1.06 | |
Dividend Yield | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 2.86 | 0.37 | 0.42 | 0.79 | 0.27 | |
Sales general and administrative to revenue | 0.08 | 0.07 | 0.08 | 0.1 | 0.08 | |
Research and developement to revenue | 0.08 | 0.09 | 0.09 | 0.14 | 0.11 | |
Intangibles to total assets | 0.09 | 0.09 | 0.1 | 0.1 | 0.1 | |
Capex to operating cash flow | -16.56 | -0.45 | -0.82 | -2.59 | -1.86 | |
Capex to revenue | -0.22 | -0.15 | -0.2 | -0.37 | -0.28 | |
Capex to depreciation | -3.26 | -1.93 | -2.71 | -4.32 | -3.45 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
Graham number | 2.39 | 6.1 | 8.03 | 5.92 | 9.77 | |
ROIC | 0.05 | 0.07 | 0.1 | 0.04 | 0.08 | |
Return on tangible assets | 0.01 | 0.06 | 0.08 | 0.04 | 0.07 | |
Graham Net | -2 | -0.9 | -1.02 | -2.74 | -3.47 | |
Working capital | 446.19M | 1.91B | 3.63B | 2.58B | 3.11B | |
Tangible asset value | 3.27B | 4.76B | 5.47B | 5.23B | 5.89B | |
Net current asset value | -948.25M | 316.09M | 256.45M | -1.88B | -2.5B | |
Invested capital | 0.87 | 0.59 | 0.62 | 0.86 | 0.91 | |
Average receivables | 1.89B | 1.75B | 1.67B | 1.95B | 2.49B | |
Average payables | 711M | 619.81M | 735.69M | 888.06M | 1.04B | |
Average inventory | 1.89B | 2.2B | 2.29B | 2.55B | 3.06B | |
Days sales outstanding | 146.03 | 99.6 | 104.97 | 111.3 | 130.32 | |
Days payables outstanding | 117.94 | 99.05 | 138.78 | 121.13 | 141.1 | |
Days of inventory on hand | 388.91 | 380.56 | 367.51 | 376.18 | 395.95 | |
Receivables turnover | 2.5 | 3.66 | 3.48 | 3.28 | 2.8 | |
Payables turnover | 3.09 | 3.68 | 2.63 | 3.01 | 2.59 | |
Inventory turnover | 0.94 | 0.96 | 0.99 | 0.97 | 0.92 | |
ROE | 0.03 | 0.1 | 0.14 | 0.07 | 0.15 | |
Capex per share | -0.86 | -0.57 | -0.88 | -1.7 | -1.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.46 | 1.69 | 1.43 | 1.55 | 1.33 | |
Net income per share | 0.16 | 0.26 | 0.12 | 0.27 | 0.11 | |
Operating cash flow per share | 0.16 | 0.26 | 0.12 | 0.36 | 0.39 | |
Free cash flow per share | -0.21 | -0.24 | -0.24 | 0.07 | 0.16 | |
Cash per share | 0.94 | 1.05 | 1.28 | 1.39 | 0.82 | |
Book value per share | 5.16 | 5.27 | 5.37 | 5.73 | 5.61 | |
Tangible book value per share | 4.1 | 4.11 | 4.19 | 4.51 | 4.38 | |
Share holders equity per share | 5.16 | 5.27 | 5.37 | 5.73 | 5.61 | |
Interest debt per share | 4.76 | 4.83 | 5.23 | 5.44 | 4.86 | |
Market cap | 26.42B | 31.32B | 29.07B | 26.58B | 24.42B | |
Enterprise value | 31.62B | 36.82B | 34.82B | 32.46B | 30.27B | |
P/E ratio | 29.16 | 20.98 | 42.02 | 16.79 | 39.97 | |
Price to sales ratio | 13.12 | 12.9 | 14.12 | 11.89 | 12.76 | |
POCF ratio | 116.66 | 83.93 | 168.08 | 51.45 | 43.53 | |
PFCF ratio | -90.32 | -89.27 | -85.51 | 268.75 | 103.19 | |
P/B Ratio | 3.72 | 4.15 | 3.76 | 3.21 | 3.02 | |
PTB ratio | 3.72 | 4.15 | 3.76 | 3.21 | 3.02 | |
EV to sales | 15.7 | 15.17 | 16.91 | 14.52 | 15.82 | |
Enterprise value over EBITDA | 63.63 | 70.24 | 103.55 | 65.63 | 103.76 | |
EV to operating cash flow | 139.6 | 98.66 | 201.32 | 62.82 | 53.96 | |
EV to free cash flow | -108.08 | -104.94 | -102.42 | 328.16 | 127.91 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | -0.01 | -0.01 | -0.01 | 0 | 0.01 | |
Debt to equity | 0.91 | 0.91 | 0.97 | 0.94 | 0.86 | |
Debt to assets | 0.38 | 0.38 | 0.4 | 0.4 | 0.38 | |
Net debt to EBITDA | 10.46 | 10.49 | 17.1 | 11.88 | 20.06 | |
Current ratio | 1.67 | 1.65 | 1.65 | 1.58 | 1.63 | |
Interest coverage | 8.04 | 9.14 | 3.75 | 7.55 | 4.02 | |
Income quality | 1 | 1 | 1 | 1.31 | 3.67 | |
Dividend Yield | 0.01 | 0 | 0 | 0.01 | 0.01 | |
Payout ratio | 0.83 | 0.13 | 0.34 | 0.66 | 1.23 | |
Sales general and administrative to revenue | 0.28 | -0.07 | 0.14 | 0 | 0.32 | |
Research and developement to revenue | 0.11 | 0.11 | 0.1 | 0.1 | 0.13 | |
Intangibles to total assets | 0.1 | 0.1 | 0.1 | 0.1 | 0.11 | |
Capex to operating cash flow | -2.29 | -1.94 | -2.97 | -0.81 | -0.58 | |
Capex to revenue | -0.26 | -0.3 | -0.25 | -0.19 | -0.17 | |
Capex to depreciation | -2.85 | -3.97 | -2.58 | -2.1 | 0.84 | |
Stock based compensation to revenue | -0.01 | 0.02 | 0 | 0.01 | -0.02 | |
Graham number | 4.37 | 5.56 | 3.81 | 5.95 | 3.66 | |
ROIC | 0.02 | 0.03 | 0.01 | 0.02 | 0.01 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Graham Net | -3.41 | -3.49 | -3.53 | -3.53 | -3.54 | |
Working capital | 2.89B | 3.11B | 3.22B | 3.23B | 2.95B | |
Tangible asset value | 5.65B | 5.89B | 6.03B | 6.51B | 6.3B | |
Net current asset value | -2.35B | -2.5B | -2.58B | -2.3B | -2.53B | |
Invested capital | 0.91 | 0.91 | 0.97 | 0.94 | 0.86 | |
Average receivables | 2.43B | 2.75B | 2.92B | 2.95B | 2.93B | |
Average payables | 989.82M | 1.09B | 1.2B | 1.24B | 1.32B | |
Average inventory | 3.22B | 3.33B | 3.36B | 3.4B | 3.49B | |
Days sales outstanding | 113.89 | 109.41 | 125.86 | 121.25 | 134.03 | |
Days payables outstanding | 110.21 | 126.33 | 127.37 | 133.58 | 145.33 | |
Days of inventory on hand | 369.26 | 354.49 | 355.99 | 359.03 | 379 | |
Receivables turnover | 0.79 | 0.82 | 0.72 | 0.74 | 0.67 | |
Payables turnover | 0.82 | 0.71 | 0.71 | 0.67 | 0.62 | |
Inventory turnover | 0.24 | 0.25 | 0.25 | 0.25 | 0.24 | |
ROE | 0.03 | 0.05 | 0.02 | 0.05 | 0.02 | |
Capex per share | -0.38 | -0.51 | -0.36 | -0.29 | -0.23 |
600521.SS Frequently Asked Questions
What is Zhejiang Huahai Pharmaceutical Co., Ltd. stock symbol ?
Zhejiang Huahai Pharmaceutical Co., Ltd. is a CN stock and trading under the symbol 600521.SS
What is Zhejiang Huahai Pharmaceutical Co., Ltd. stock quote today ?
Zhejiang Huahai Pharmaceutical Co., Ltd. stock price is $12.92 today.
Is Zhejiang Huahai Pharmaceutical Co., Ltd. stock public?
Yes, Zhejiang Huahai Pharmaceutical Co., Ltd. is a publicly traded company.